Literature DB >> 1946778

New therapy for treating hypernasal speech using continuous positive airway pressure (CPAP).

D P Kuehn1.   

Abstract

The purpose of this report is to introduce a new therapy technique for treating hypernasality. The instrumentation consists of a continuous positive airway pressure (CPAP) device that delivers air pressure by means of a hose and nasal mask assembly to the nasal cavities. This positive pressure is theoretically useful in providing resistance training to strengthen the velopharyngeal closure muscles. Speech drillwork is conducted in the patient's home and consists of production of VNCV syllables and short sentences with the nasal mask worn by the patient. Incremental changes in CPAP pressure and time per therapy session occur over an 8-week course of therapy. Six case studies are presented. The preliminary results suggest that CPAP therapy may be effective in reducing hypernasality in individuals exhibiting mild to moderate degrees of severity.

Entities:  

Mesh:

Year:  1991        PMID: 1946778     DOI: 10.1097/00006534-199112000-00003

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  3 in total

1.  Change in levator veli palatini muscle activity in relation to swallowing volume during the transition from the oral phase to pharyngeal phase.

Authors:  Takashi Tachimura; Kentaro Okuno; Maki Ojima; Kanji Nohara
Journal:  Dysphagia       Date:  2006-01       Impact factor: 3.438

2.  A pilot study shows the positive effects of continuous airway pressure for treating hypernasal speech in children with infantile-onset Pompe disease.

Authors:  Yin-Ting Zeng; Wen-Yu Liu; Pao-Chuan Torng; Wuh-Liang Hwu; Ni-Chung Lee; Chun-Yi Lin; Yin-Hsiu Chien
Journal:  Sci Rep       Date:  2021-09-22       Impact factor: 4.379

3.  Effects of noninvasive ventilation on the coordination between breathing and swallowing in patients with chronic obstructive pulmonary disease.

Authors:  Ryuji Hori; Rika Ishida; Masaaki Isaka; Takahito Nakamura; Yoshitaka Oku
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2019-07-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.